Arcturus Therapeutics (ARCT) had its price target lowered by Citigroup Inc. from $66.00 to $21.00. They now have a "buy" rating on the stock.
Arcturus Therapeutics to Attend Upcoming Investor Conference
Arcturus Therapeutics (ARCT) had its price target raised by Citigroup Inc. from $7.00 to $8.00. They now have a "neutral" rating on the stock.
Arcturus Therapeutics (ARCT) had its price target lowered by Piper Sandler from $72.00 to $25.00. They now have an "overweight" rating on the stock.
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]